SEARCH

SEARCH BY CITATION

References

  • Arnaud C., Burger F., Steffens S., Veillard N. R., Nguyen T. H., Trono D. and Mach F. (2005) Statins reduce interleukin-6-induced C-reactive protein in human hepatocytes: new evidence for direct antiinflammatory effects of statins. Arterioscler. Thromb. Vasc. Biol. 25, 12311236.
  • Asanuma Y., Oeser A., Stanley E., Bailey D. G., Shintani A. and Stein C. M. (2008) Effects of C-reactive protein and homocysteine on cytokine production: modulation by pravastatin. Arch. Drug Inf. 1, 1422.
  • Bokura H., Kobayashi S., Yamaguchi S., Iijima K., Nagai A., Toyoda G., Oguro H. and Takahashi K. (2006) Silent brain infarction and subcortical white matter lesions increase the risk of stroke and mortality: a prospective cohort study. J. Stroke Cerebrovasc. Dis. 15, 5763.
  • Bradley M. A., Markesbery W. R. and Lovell M. A. (2010) Increased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer disease. Free Radic. Biol. Med. 48, 15701576.
  • Cheng Y. C., Liang C. M., Chen Y. P., Tsai I. H., Kuo C. C. and Liang S. M. (2009) F-spondin plays a critical role in murine neuroblastoma survival by maintaining IL-6 expression. J. Neurochem. 110, 947955.
  • Esterbauer H., Schaur R. J. and Zollner H. (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11, 81128.
  • Fujita T., Tozaki-Saitoh H. and Inoue K. (2009) P2Y1 receptor signaling enhances neuroprotection by astrocytes against oxidative stress via IL-6 release in hippocampal cultures. Glia 57, 244257.
  • Higashi K., Terui Y., Suganami A., Tamura Y., Nishimura K., Kashiwagi K. and Igarashi K. (2008) Selective structural change by spermidine in the bulged-out region of double-stranded RNA and its effect on RNA function. J. Biol. Chem. 283, 3298932994.
  • Higashi K., Yoshida M., Igarashi A. et al. (2010) Intense correlation between protein-conjugated acrolein and primary Sjogren's syndrome. Clin. Chim. Acta 411, 359363.
  • Hoshi T., Kitagawa K., Yamagami H., Furukado S., Hougaku H. and Hori M. (2005) Relations of serum high-sensitivity C-reactive protein and interleukin-6 levels with silent brain infarction. Stroke 36, 768772.
  • Igarashi K. and Kashiwagi K. (2010) Modulation of cellular function by polyamines. Int. J. Biochem. Cell Biol. 42, 3951.
  • Igarashi K. and Kashiwagi K. (2011) Protein-conjugated acrolein as a biochemical marker of brain infarction. Mol. Nutr. Food Res. 55, 13321341.
  • Igarashi K., Ueda S., Yoshida K. and Kashiwagi K. (2006) Polyamines in renal failure. Amino Acids 31, 477483.
  • Inoue K., Matsumoto M., Shono T., Toyokawa S. and Moriki A. (2007) Increased intima media thickness and atherosclerotic plaques in the carotid artery as risk factors for silent brain infarcts. J. Stroke Cerebrovasc. Dis. 16, 1420.
  • Jones S. A., Novick D., Horiuchi S., Yamamoto N., Szalai A. J. and Fuller G. M. (1999) C-reactive protein: a physiological activator of interleukin 6 receptor shedding. J. Exp. Med. 189, 599604.
  • Kishimoto T. (1989) The biology of interleukin-6. Blood 74, 110.
  • Kobayashi S., Okada K., Koide H., Bokura H. and Yamaguchi S. (1997) Subcortical silent brain infarction as a risk factor for clinical stroke. Stroke 28, 19321939.
  • Kobayashi K., Yoshida A., Ejiri Y., Takagi S., Mimura H., Hosoda M., Matsuura T. and Chiba K. (2012) Increased expression of drug-metabolizing enzymes in human hepatocarcinoma FLC-4 cells cultured on micro-space cell culture plates. Drug Metab. Pharmacokinet. 27, 478485.
  • Lowry O. H., Rosebrough N. J., Farr A. L. and Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265275.
  • Moreau M. F., Guillet C., Massin P., Chevalier S., Gascan H., Basle M. F. and Chappard D. (2007) Comparative effects of five bisphosphonates on apoptosis of macrophage cells in vitro. Biochem. Pharmacol. 73, 718723.
  • Ndlovu M. N., Van Lint C., Van Wesemael K., Callebert P., Chalbos D., Haegeman G. and Vanden Berghe W. (2009) Hyperactivated NF-κB and AP-1 transcription factors promote highly accessible chromatin and constitutive transcription across the interleukin-6 gene promoter in metastatic breast cancer cells. Mol. Cell. Biol. 29, 54885504.
  • Nielsen P. J., Manchester K. L., Towbin H., Gordon J. and Thomas G. (1982) The phosphorylation of ribosomal protein S6 in rat tissues following cycloheximide injection, in diabetes, and after denervation of diaphragm. A simple immunological determination of the extent of S6 phosphorylation on protein blots. J. Biol. Chem. 257, 1231612321.
  • Saiki R., Nishimura K., Ishii I., Omura T., Okuyama S., Kashiwagi K. and Igarashi K. (2009) Intense correlation between brain infarction and protein-conjugated acrolein. Stroke 40, 33563361.
  • Saiki R., Park H., Ishii I. et al. (2011) Brain infarction correlates more closely with acrolein than with reactive oxygen species. Biochem. Biophys. Res. Commun. 404, 10441049.
  • Sharmin S., Sakata K., Kashiwagi K., Ueda S., Iwasaki S., Shirahata A. and Igarashi K. (2001) Polyamine cytotoxicity in the presence of bovine serum amine oxidase. Biochem. Biophys. Res. Commun. 282, 228235.
  • Sun H., Koike T., Ichikawa T. et al. (2005) C-reactive protein in atherosclerotic lesions: its origin and pathophysiological significance. Am. J. Pathol. 167, 11391148.
  • Tanabe M., Tabuchi S., Iwatsuki M., Kurosaki M., Kamitani H., Yokota M. and Watanabe T. (2004) Incorporation of arachidonic and linoleic acid hydroperoxides into cultured human umbilical vein endothelial cells. Prostaglandins Leukot. Essent. Fatty Acids 70, 485489.
  • Tanaka Y., Marumo T., Omura T. and Yoshida S. (2007) Quantitative assessments of cerebral vascular damage with a silicon rubber casting method in photochemically-induced thrombotic stroke rat models. Life Sci. 81, 13811388.
  • Tomitori H., Usui T., Saeki N., Ueda S., Kase H., Nishimura K., Kashiwagi K. and Igarashi K. (2005) Polyamine oxidase and acrolein as novel biochemical markers for diagnosis of cerebral stroke. Stroke 36, 26092613.
  • Tomitori H., Nakamura M., Sakamoto A., Terui Y., Yoshida M., Igarashi K. and Kashiwagi K. (2012) Augmented glutathione synthesis decreases acrolein toxicity. Biochem. Biophys. Res. Commun. 418, 110115.
  • Uchida K., Kanematsu M., Morimitsu Y., Osawa T., Noguchi N. and Niki E. (1998) Acrolein is a product of lipid peroxidation reaction. Formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins. J. Biol. Chem. 273, 1605816066.
  • Vermeer S. E., Longstreth W. T. Jr and Koudstaal P. J. (2007) Silent brain infarcts: a systematic review. Lancet Neurol. 6, 611619.
  • Waragai M., Yoshida M., Mizoi M. et al. (2012) Increased protein-conjugated acrolein and amyloid-β40/42 ratio in plasma of patients with mild cognitive impairment and Alzheimer's disease. J. Alzheimers Dis. 32, 3341.
  • Yoshida M., Higashi K., Kobayashi E. et al. (2010) Correlation between images of silent brain infarction, carotid atherosclerosis and white matter hyperintensity, and plasma levels of acrolein, IL-6 and CRP. Atherosclerosis 211, 475479.
  • Yoshida M., Mikami T., Higashi K. et al. (2012) Inverse correlation between stroke and urinary 3-hydroxypropyl mercapturic acid, an acrolein-glutathione metabolite. Clin. Chim. Acta 413, 753759.